Clinical trial
Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children With Intestinal Failure
NCT02515201 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children With Intestinal Failure
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- December 31, 2016
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.